US Stock MarketDetailed Quotes

United Therapeutics (UTHR)

Watchlist
  • 567.160
  • -5.690-0.99%
Close Apr 24 15:59 ET
  • 567.160
  • 0.0000.00%
Post 20:01 ET
24.86BMarket Cap20.36P/E (TTM)

United Therapeutics (UTHR) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
17.64%1.56B
1.47%346.2M
49.02%562.1M
-17.44%191.7M
22.50%461.2M
35.70%1.33B
126.41%341.2M
8.95%377.2M
118.44%232.2M
0.45%376.5M
Net income from continuing operations
11.68%1.33B
20.91%364.3M
9.58%338.7M
11.29%309.5M
5.09%322.2M
21.35%1.2B
38.78%301.3M
15.51%309.1M
7.29%278.1M
27.27%306.6M
Depreciation and amortization
18.07%85.6M
15.74%22.8M
14.66%21.9M
12.83%21.1M
32.00%19.8M
36.28%72.5M
43.80%19.7M
43.61%19.1M
44.96%18.7M
12.78%15M
Deferred tax
252.42%97.7M
----
----
----
----
0.47%-64.1M
----
----
----
----
Other non cash items
18.93%-19.7M
-1,192.31%-33.6M
98.25%-100K
183.64%4.6M
189.52%9.4M
-395.92%-24.3M
48.00%-2.6M
-216.67%-5.7M
-41.03%-5.5M
-281.03%-10.5M
Change In working capital
-2,830.77%-106.5M
-340.40%-144M
1,150.00%162.5M
-86.58%-203M
95.98%78M
111.68%3.9M
319.41%59.9M
-71.74%13M
39.32%-108.8M
-68.71%39.8M
-Change in receivables
-17,625.00%-70.9M
-184.00%-52.5M
259.69%81.6M
-447.27%-57.3M
-50.88%-42.7M
99.32%-400K
407.88%62.5M
-465.00%-51.1M
111.95%16.5M
-132.95%-28.3M
-Change in inventory
-12.15%-52.6M
-42.24%-16.5M
-54.87%-17.5M
49.66%-7.4M
-20.43%-11.2M
-244.85%-46.9M
-65.71%-11.6M
-264.52%-11.3M
-1,370.00%-14.7M
-272.00%-9.3M
-Change in payables and accrued expense
129.27%97.9M
228.89%23.2M
-5.45%31.2M
78.68%46.1M
-236.84%-2.6M
-25.22%42.7M
22.08%-18M
-16.24%33M
-32.11%25.8M
-32.14%1.9M
-Change in other working capital
-1,051.76%-80.9M
-463.70%-98.2M
58.49%67.2M
-35.19%-184.4M
78.15%134.5M
146.20%8.5M
16.88%27M
1,086.05%42.4M
-74.42%-136.4M
84.15%75.5M
Cash from discontinued investing activities
Operating cash flow
17.64%1.56B
1.47%346.2M
49.02%562.1M
-17.44%191.7M
22.50%461.2M
35.70%1.33B
126.41%341.2M
8.95%377.2M
118.44%232.2M
0.45%376.5M
Investing cash flow
Cash flow from continuing investing activities
-232.14%-551.3M
-84.74%-227.6M
222.63%140.9M
-274.88%-299.9M
-122.40%-164.7M
157.98%417.2M
-392.64%-123.2M
63.34%-114.9M
64.79%-80M
432.56%735.3M
Net PPE purchase and sale
-111.16%-520.5M
-99.42%-172.9M
-175.16%-210.5M
-37.92%-62.2M
-96.07%-74.9M
-6.99%-246.5M
-10.17%-86.7M
-16.44%-76.5M
-0.89%-45.1M
7.51%-38.2M
Net intangibles purchase and sale
---5.5M
--0
----
----
----
--0
--0
----
----
----
Net business purchase and sale
-80.33%-55M
16.67%-25M
---30M
----
----
65.81%-30.5M
66.37%-30M
--0
----
----
Net investment purchase and sale
-94.45%40.1M
-6,860.00%-34.8M
2,005.83%392.6M
-597.35%-237.1M
-110.36%-80.6M
291.70%722.7M
-100.23%-500K
91.31%-20.6M
80.98%-34M
532.59%777.8M
Net other investing changes
63.51%-10.4M
185.00%5.1M
67.98%-5.7M
-50.00%-600K
-113.95%-9.2M
-23.91%-28.5M
31.03%-6M
-67.92%-17.8M
---400K
---4.3M
Cash from discontinued investing activities
Investing cash flow
-232.14%-551.3M
-84.74%-227.6M
222.63%140.9M
-274.88%-299.9M
-122.40%-164.7M
157.98%417.2M
-392.64%-123.2M
63.34%-114.9M
64.79%-80M
432.56%735.3M
Financing cash flow
Cash flow from continuing financing activities
8.35%-1.15B
231.73%98.4M
-1,391.42%-956M
-313.75%-198.6M
91.22%-93.8M
-10,444.54%-1.25B
19.50%-74.7M
-943.42%-64.1M
-294.33%-48M
-2,297.53%-1.07B
Net issuance payments of debt
25.00%-300M
--0
--0
-100.00%-200M
0.00%-100M
-300.00%-400M
0.00%-100M
---100M
---100M
---100M
Net common stock issuance
-0.43%-1.02B
1,566.67%4.4M
-250,025.00%-1B
-78.26%-20.5M
--0
-7,234.78%-1.01B
-200.00%-300K
-100.00%-400K
14.81%-11.5M
---1B
Proceeds from stock option exercised by employees
14.37%183.1M
286.72%99M
22.59%44.5M
-65.26%18.1M
-53.36%21.5M
53.06%160.1M
250.68%25.6M
365.38%36.3M
110.93%52.1M
-28.86%46.1M
Net other financing activities
-511.11%-16.5M
---5M
--0
-66.67%3.8M
-8.51%-15.3M
0.00%-2.7M
--0
--0
-15.56%11.4M
12.96%-14.1M
Cash from discontinued financing activities
Financing cash flow
8.35%-1.15B
231.73%98.4M
-1,391.42%-956M
-313.75%-198.6M
91.22%-93.8M
-10,444.54%-1.25B
19.50%-74.7M
-943.42%-64.1M
-294.33%-48M
-2,297.53%-1.07B
Net cash flow
Beginning cash position
40.53%1.7B
-13.76%1.34B
17.51%1.59B
51.81%1.9B
40.53%1.7B
25.65%1.21B
40.28%1.55B
27.02%1.36B
7.56%1.25B
25.65%1.21B
Current changes in cash
-128.62%-140.1M
51.43%217M
-227.65%-253M
-394.43%-306.8M
362.79%202.7M
98.58%489.5M
43.30%143.3M
390.59%198.2M
208.32%104.2M
-78.35%43.8M
End cash Position
-8.25%1.56B
-8.25%1.56B
-13.76%1.34B
17.51%1.59B
51.81%1.9B
40.53%1.7B
40.53%1.7B
40.28%1.55B
27.02%1.36B
7.56%1.25B
Free cash flow
-4.20%1.04B
-31.91%173.3M
15.10%346.1M
-30.79%129.5M
14.19%386.3M
44.54%1.08B
253.47%254.5M
7.20%300.7M
203.73%187.1M
1.44%338.3M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 17.64%1.56B1.47%346.2M49.02%562.1M-17.44%191.7M22.50%461.2M35.70%1.33B126.41%341.2M8.95%377.2M118.44%232.2M0.45%376.5M
Net income from continuing operations 11.68%1.33B20.91%364.3M9.58%338.7M11.29%309.5M5.09%322.2M21.35%1.2B38.78%301.3M15.51%309.1M7.29%278.1M27.27%306.6M
Depreciation and amortization 18.07%85.6M15.74%22.8M14.66%21.9M12.83%21.1M32.00%19.8M36.28%72.5M43.80%19.7M43.61%19.1M44.96%18.7M12.78%15M
Deferred tax 252.42%97.7M----------------0.47%-64.1M----------------
Other non cash items 18.93%-19.7M-1,192.31%-33.6M98.25%-100K183.64%4.6M189.52%9.4M-395.92%-24.3M48.00%-2.6M-216.67%-5.7M-41.03%-5.5M-281.03%-10.5M
Change In working capital -2,830.77%-106.5M-340.40%-144M1,150.00%162.5M-86.58%-203M95.98%78M111.68%3.9M319.41%59.9M-71.74%13M39.32%-108.8M-68.71%39.8M
-Change in receivables -17,625.00%-70.9M-184.00%-52.5M259.69%81.6M-447.27%-57.3M-50.88%-42.7M99.32%-400K407.88%62.5M-465.00%-51.1M111.95%16.5M-132.95%-28.3M
-Change in inventory -12.15%-52.6M-42.24%-16.5M-54.87%-17.5M49.66%-7.4M-20.43%-11.2M-244.85%-46.9M-65.71%-11.6M-264.52%-11.3M-1,370.00%-14.7M-272.00%-9.3M
-Change in payables and accrued expense 129.27%97.9M228.89%23.2M-5.45%31.2M78.68%46.1M-236.84%-2.6M-25.22%42.7M22.08%-18M-16.24%33M-32.11%25.8M-32.14%1.9M
-Change in other working capital -1,051.76%-80.9M-463.70%-98.2M58.49%67.2M-35.19%-184.4M78.15%134.5M146.20%8.5M16.88%27M1,086.05%42.4M-74.42%-136.4M84.15%75.5M
Cash from discontinued investing activities
Operating cash flow 17.64%1.56B1.47%346.2M49.02%562.1M-17.44%191.7M22.50%461.2M35.70%1.33B126.41%341.2M8.95%377.2M118.44%232.2M0.45%376.5M
Investing cash flow
Cash flow from continuing investing activities -232.14%-551.3M-84.74%-227.6M222.63%140.9M-274.88%-299.9M-122.40%-164.7M157.98%417.2M-392.64%-123.2M63.34%-114.9M64.79%-80M432.56%735.3M
Net PPE purchase and sale -111.16%-520.5M-99.42%-172.9M-175.16%-210.5M-37.92%-62.2M-96.07%-74.9M-6.99%-246.5M-10.17%-86.7M-16.44%-76.5M-0.89%-45.1M7.51%-38.2M
Net intangibles purchase and sale ---5.5M--0--------------0--0------------
Net business purchase and sale -80.33%-55M16.67%-25M---30M--------65.81%-30.5M66.37%-30M--0--------
Net investment purchase and sale -94.45%40.1M-6,860.00%-34.8M2,005.83%392.6M-597.35%-237.1M-110.36%-80.6M291.70%722.7M-100.23%-500K91.31%-20.6M80.98%-34M532.59%777.8M
Net other investing changes 63.51%-10.4M185.00%5.1M67.98%-5.7M-50.00%-600K-113.95%-9.2M-23.91%-28.5M31.03%-6M-67.92%-17.8M---400K---4.3M
Cash from discontinued investing activities
Investing cash flow -232.14%-551.3M-84.74%-227.6M222.63%140.9M-274.88%-299.9M-122.40%-164.7M157.98%417.2M-392.64%-123.2M63.34%-114.9M64.79%-80M432.56%735.3M
Financing cash flow
Cash flow from continuing financing activities 8.35%-1.15B231.73%98.4M-1,391.42%-956M-313.75%-198.6M91.22%-93.8M-10,444.54%-1.25B19.50%-74.7M-943.42%-64.1M-294.33%-48M-2,297.53%-1.07B
Net issuance payments of debt 25.00%-300M--0--0-100.00%-200M0.00%-100M-300.00%-400M0.00%-100M---100M---100M---100M
Net common stock issuance -0.43%-1.02B1,566.67%4.4M-250,025.00%-1B-78.26%-20.5M--0-7,234.78%-1.01B-200.00%-300K-100.00%-400K14.81%-11.5M---1B
Proceeds from stock option exercised by employees 14.37%183.1M286.72%99M22.59%44.5M-65.26%18.1M-53.36%21.5M53.06%160.1M250.68%25.6M365.38%36.3M110.93%52.1M-28.86%46.1M
Net other financing activities -511.11%-16.5M---5M--0-66.67%3.8M-8.51%-15.3M0.00%-2.7M--0--0-15.56%11.4M12.96%-14.1M
Cash from discontinued financing activities
Financing cash flow 8.35%-1.15B231.73%98.4M-1,391.42%-956M-313.75%-198.6M91.22%-93.8M-10,444.54%-1.25B19.50%-74.7M-943.42%-64.1M-294.33%-48M-2,297.53%-1.07B
Net cash flow
Beginning cash position 40.53%1.7B-13.76%1.34B17.51%1.59B51.81%1.9B40.53%1.7B25.65%1.21B40.28%1.55B27.02%1.36B7.56%1.25B25.65%1.21B
Current changes in cash -128.62%-140.1M51.43%217M-227.65%-253M-394.43%-306.8M362.79%202.7M98.58%489.5M43.30%143.3M390.59%198.2M208.32%104.2M-78.35%43.8M
End cash Position -8.25%1.56B-8.25%1.56B-13.76%1.34B17.51%1.59B51.81%1.9B40.53%1.7B40.53%1.7B40.28%1.55B27.02%1.36B7.56%1.25B
Free cash flow -4.20%1.04B-31.91%173.3M15.10%346.1M-30.79%129.5M14.19%386.3M44.54%1.08B253.47%254.5M7.20%300.7M203.73%187.1M1.44%338.3M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------
Market Insights
China Concept Stocks
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More